The operation Drager Medical AG (“Drager”) develops, manufactures and sells products, services and integrated solutions for acute patient care, including neo-natal warming therapy products. Air-Shields' main business comprises the manufacturing of warming therapy devices for infant care. Drager proposed to acquire certain assets of the Air-Shields business relating to the manufacture (in the USA) and worldwide supply of neo-natal warming therapy products. The acquisition was referred to the Competition Commission on 18 December 2003. The market(s) The Competition Commission identified separate product markets for four types of neonatal warming therapy products: (i) closed care incubators; (ii) open care warming beds; (iii) transport incubators; and
Share on
|
|
The UK Competition Commission cleared a merger in the healthcare sector with remedies, including behavioural undertakings to maintain current products and services and price control (Drager Medical / Air-Shields)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
